Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study by Lix, Lisa M et al.
SHORT REPORT Open Access
Measurement equivalence of the SF-36 in the
canadian multicentre osteoporosis study
Lisa M Lix
1*, Beliz Acan Osman
2†, Jonathan D Adachi
3†, Tanveer Towheed
4†, Wilma Hopman
4†, K Shawn Davison
5†
and William D Leslie
6†
Abstract
Background: Studies that compare health-related quality of life (HRQOL) and other patient-reported outcomes in
different populations rest on the assumption that the measure has equivalent psychometric properties across
groups. This study examined the measurement equivalence (ME) of the 36-item Medical Outcomes Study Short
Form Survey (SF-36), a widely-used measure of HRQOL, by sex and race in a population-based Canadian sample.
Findings: SF-36 data were from the Canadian Multicentre Osteoporosis Study, a prospective cohort study that
randomly sampled adult men and women from nine sites across Canada. Confirmatory factor analysis (CFA)
techniques were used to test hypotheses about four forms of ME, which are based on equality of the factor
loadings, variances, covariances, and intercepts. Analyses were conducted for Caucasian and non-Caucasian females
(n = 6,539) and males (n = 2,884). CFA results revealed that a measurement model with physical and mental health
factors provided a good fit to the data. All forms of ME were satisfied for the study groups.
Conclusions: The results suggest that sex and race do not influence the conceptualization of a general measure of
HRQOL in the Canadian population.
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Findings
The psychometric properties of health-related quality of
life (HRQOL) measures and other patient-reported out-
comes are an important consideration when undertaking
studies in populations with diverse cultural or racial
compositions [1]. The Medical Outcomes Study 36-item
Short Form Survey (SF-36) is a well-known HRQOL
measure used in many countries. While studies have
been undertaken about its reliability and validity in dif-
ferent populations [2], its measurement equivalence
(ME) properties have not been well examined. ME eva-
luations seek to answer the question: “Do individuals
from different populations interpret a measure in a con-
ceptually similar manner?” [3]. If ME is not tenable,
then researchers cannot validly conclude that differences
between groups correspond to true population differ-
ences because they will be confounded by measurement
artifact. Measurement non-equivalence may exist, in
part, because study participants do not interpret
questions about their health using the same frame of
reference [4,5].
The purpose of this study is to investigate the ME of
the SF-36 by sex and race. We focus on its properties in
the Canadian population, where normative data for the
SF-36 have now been published [6].
Methods
Study data were from the Canadian Multicentre
Osteoporosis Study (CaMos), an ongoing prospective
cohort study undertaken to provide national estimates
of the prevalence and incidence of osteoporosis and
osteoporosis-related fractures. The study population is
composed of non-institutionalized men and women
residing within a 50-km radius of nine centers across
Canada. These geographic areas encompass approxi-
mately 40 percent of the national population and
include rural and urban residents. A random sample
was taken from each site; details of the data collection
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reported previously [6,7].
The sample consisted of all CaMos respondents for
whom baseline data were obtained. Data collection
occurred between January 1996 and September 1997 by
means of an interviewer-administered questionnaire.
Informed consent was obtained from participants and
ethical approval was provided by the review boards of
each participating center and the coordinating center in
Montreal.
The SF-36 encompasses eight domains: physical func-
tioning (PF), role physical (RP), bodily pain (BP), general
health (GH), vitality (VT), social functioning (SF), role
emotional (RE), and mental health (MH). Each domain
is scored on a standardized scale with values ranging
from 0 to 100. Higher scores indicate better HRQOL
[8]. In previous Canadian research, Cronbach’s a ranged
from 0.76 to 0.93 for the eight domains, with the lowest
value for the SF domain [9]. Test-retest reliability has
not been reported for the Canadian population, but in
other populations a median reliability greater than 0.80
was reported for all but the SF domain, which had a
median reliability of 0.76 [10].
Race, age in years, and sex were recorded during the
interviews. For race, respondents were initially assigned
to Caucasian, Asian, and Other categories. These cate-
gories were subsequently collapsed into Caucasian and
non-Caucasian.
The data were described using frequencies and means.
Hypotheses about ME were initially tested for the fol-
lowing pairs of study groups: (a) Caucasian and non-
Caucasian females, (b) Caucasian and non-Caucasian
males, (c) Caucasian males and females, and (d) non-
Caucasian males and females. Subsequently, we tested
ME hypotheses in age-matched groups, in which non-
Caucasians were matched with Caucasians using age (in
years) as the matching variable. The latter analyses were
conducted to adjust for the potential confounding
effects of age.
Four forms of ME were investigated using confirma-
tory factor analysis (CFA) [3,11,12]: configural, weak,
strong, and complete. A series of two-group CFA mod-
els were fit to the data for each pair of study groups.
Weak, strong, and complete invariance was tested in
sequence by placing constraints on the parameters (i.e.,
factor loadings, intercepts, and error variances) of the
configural invariance model [3,11]. Configural invar-
iance, the simplest form of ME, is satisfied if a defined
factor structure is a good fit to the data for both groups.
It was evaluated using absolute and incremental good-
ness-of-fit statistics and published cut-off criteria
[13-15]. The statistics included the model c
2, root mean
square error of approximation (RMSEA) and its 90%
confidence interval (CI), root mean squared residual
(SRMR), comparative fit index (CFI) and non-normed fit
index (NNFI). Model modification indices were calcu-
lated for the configural invariance model to guide deci-
sions about its specification. These indices measure the
predicted change in the c
2 statistic if a parameter is
added or removed from the model and re-estimated.
A test of weak invariance assesses whether the factor
loadings are the same for the groups. When weak invar-
iance is satisfied, the latent variables are being measured
in the same way for the groups. A test of strong invar-
iance is used to assess whether the factor loadings and
latent variable intercepts (i.e., means) are the same for
the groups. If strong invariance does not hold then it is
not valid to make group comparisons on the domain
means. Complete invariance holds if the factor loadings,
intercepts, and error variances are equivalent for the
groups [11]. A LR statistic based on the difference in c
2
values for unconstrained and constrained models (i.e., Δ
c
2), was used to test weak, strong, and complete invar-
iance. The difference in CFI values for nested models (i.
e., ΔCFI) was also used to assess invariance because the
LR statistic is sensitive to sample size. An absolute value
of ΔCFI less than or equal to 0.01 indicates the null
hypothesis of invariance should not be rejected, while
an absolute value greater than or equal to 0.02 indicates
a likely difference in fit between constrained and uncon-
strained models [16]. ΔCFI was given more weight than
the LR test when there was disagreement between the
two statistics.
Robust maximum likelihood was used to estimate
model parameters because the data exhibited a multi-
variate non-normal distribution [17]. Accordingly,
Satorra-Bentler (SB)-scaled c
2 statistics, which correct
for non-normality using RML were adopted [18]. Ana-
lyses were conducted using LISREL 8.80 [19].
Results
Data for 9,423 CaMos participants (Table 1) were
included in the analysis. Two-thirds of participants were
female. The majority (94.9%) was Caucasian and this
percentage was similar for males and females. Average
scores for each of the SF-36 domains (Table 2) revealed
that males tended to have higher HRQOL than females.
For females, scores for Caucasians were often lower
than those for non-Caucasians. For males, this was not
always the case.
The initial configural invariance model (Figure 1) was
fit to the data for each study group. This model was
selected based on previous research that supports a two-
factor model with four domains each measuring physical
and mental health latent variables [10]. Based on the c
2
statistic, RMSEA, and SRMR (Table 3), this model did
not provide a good fit to the data. Model modification
indices suggested that substantial improvement in fit
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residual errors of the SF-36 domains for RP and GH,
VT and SF, and RP and RE. With these modifications
(Table 3), all goodness-of-fit statistics indicated a well-
fitting model.
The hypothesis of weak invariance was tested for this
measurement model (Table 4). It was retained for all
pairs of subgroups based on the ΔCFI, although the LR
statistic was statistically significant for Caucasian and
non-Caucasian females. The null hypothesis of strong
invariance was retained for all pairs of study groups
based on the ΔCFI statistics. Finally, the hypothesis of
complete invariance was retained for all pairs of study
groups according to ΔCFI statistics. Subsequent analyses
for the age-matched study groups resulted in the same
conclusions about all ME hypotheses.
Discussion
This study investigated the psychometric equivalence of
the SF-36 by sex and race in a population-based cohort
that represents a large proportion of the Canadian
population. These stratification variables were selected
because previous research indicates they are associated
with differences in the conceptualization of HRQOL and
other patient-reported outcomes [2]. All forms of ME
were supported in each of the four analyses.
Table 1 Distribution of the CaMos cohort by sex, age, and race
Age (years) Female Male
Caucasian Asian Other Caucasian Asian Other
n % n% n% n % n% n %
25-49 902 14.1 30 22.1 41 29.3 639 23.8 28 26.9 30 30.9
50-59 1,274 20.3 40 20.4 38 27.1 554 20.7 18 17.3 30 30.9
60-69 1,963 31.3 42 30.9 39 27.9 711 26.5 25 24.0 23 23.7
70+ 2,124 33.9 24 17.7 22 15.7 779 29.0 33 31.7 14 14.4
Total 6,263 100.0 136 100.0 140 100.0 2683 100.0 104 100.0 97 100.0
Table 2 Means and standard deviations (SDs) for the SF-
36 domains
Domain Race Female Male
Physical functioning Caucasian 73.49 (25.32) 81.33 (22.27)
Non-Caucasian 79.69 (21.18) 82.17 (21.57)
All Groups 73.75 (25.19) 81.39 (22.22)
Role physical Caucasian 74.08 (38.16) 81.50 (33.28)
Non-Caucasian 79.62 (35.85) 81.84 (33.72)
All Groups 74.31 (38.08) 81.53 (33.31)
Bodily pain Caucasian 70.82 (24.61) 76.79 (22.46)
Non-Caucasian 76.00 (24.18) 79.41 (24.25)
All Groups 71.04 (24.61) 76.97 (22.59)
General health Caucasian 73.92 (19.04) 74.69 (17.90)
Non-Caucasian 70.95 (19.37) 73.37 (19.19)
All Groups 73.80 (19.06) 74.59 (17.99)
Vitality Caucasian 62.63 (19.87) 67.80 (17.83)
Non-Caucasian 64.74 (19.42) 68.93 (17.23)
All Groups 62.71 (19.85) 67.88 (17.78)
Social functioning Caucasian 85.49 (21.37) 89.03 (18.71)
Non-Caucasian 84.60 (21.42) 83.21 (22.21)
All Groups 85.46 (21.37) 88.62 (19.03)
Role emotional Caucasian 83.56 (32.07) 87.90 (27.82)
Non-Caucasian 82.61 (34.75) 82.26 (33.83)
All Groups 83.52 (32.19) 87.50 (28.31)
Mental health Caucasian 77.78 (15.56) 81.09 (13.89)
Non-Caucasian 78.23 (16.91) 80.89 (14.89)
All Groups 77.80 (15.62) 81.08 (13.95)
The non-Caucasian group includes Asian and Other groups
Figure 1 Initial configural invariance model for the SF-36.T h e
circles represent the SF-36 physical and mental health latent factors,
the rectangles represent measured indicators (i.e., the domains), the
lines connecting latent factors to indicators are factor loadings, and
the curve connecting the two latent factors represents covariation.
Numbers provided are standardized values for female Caucasians
and male Caucasians (in parentheses).
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ME of the SF-36. While configural and weak invariance
are usually tested, Gregorich [20] notes that strong and
complete invariance are less frequently considered,
despite the fact that equality of factor loadings, inter-
cepts, and error variances is critical to making valid
group comparisons [21]. Vandenberg and Lance [11]
found that weak invariance was investigated in 99% of
studies but strong invariance was tested in only about
12% of studies. However, this research also has some
limitations. ME was investigated for a single measure;
other measures of HRQOL might not be psychometri-
cally equivalent. Other stratification variables may have
been considered in the ME models, such as education
[22]. However, further stratification of the data would
have resulted in sample sizes too small to result in valid
tests of the study hypotheses. The initial factor structure
selected for the SF-36 domains did not provide a good
fit to the data. It was modified to allow for correlation
among the residual errors of selected domains. While
this model was consistent with previous research [23], it
may not be consistent with the measurement model
adopted in other studies. Finally, only a single statistical
method, CFA, was used to test ME. Item response the-
ory has also been proposed for evaluating equivalence
and these approaches may not concur [24].
Establishing ME across populations is a prerequisite
for conducting valid tests of hypotheses about equality
of group means or variances. The findings of this study
suggest that sex and race do not influence the concep-
tualization of a general measure of HRQOL in the
Canadian population.
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